China Biologic Announces Completion of Going Private Transaction PR Newswire BEIJING, April 20, 2021 BEIJING, April 20, 2021 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO...
China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2020 PR Newswire BEIJING, March 29, 2021 BEIJING, March 29, 2021 /PRNewswire/ -- China Biologic Products Holdings...
China Biologic Announces Shareholders' Approval of Merger Agreement PR Newswire BEIJING, March 1, 2021 BEIJING, March 1, 2021 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO...
China Biologic Announces Extraordinary General Meeting of Shareholders PR Newswire BEIJING, Jan. 25, 2021 BEIJING, Jan. 25, 2021 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ:...
China Biologic Reports Financial Results for the Third Quarter of 2020 PR Newswire BEIJING, Nov. 24, 2020 BEIJING, Nov. 24, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ:...
China Biologic Enters into Definitive Merger Agreement for Going Private Transaction PR Newswire BEIJING, Nov. 19, 2020 BEIJING, Nov. 19, 2020 /PRNewswire/ -- China Biologic Products Holdings...
China Biologic Products to Report Third Quarter 2020 Financial Results PR Newswire BEIJING, Nov. 13, 2020 BEIJING, Nov. 13, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ:...
China Biologic Reports Financial Results for the Second Quarter of 2020 PR Newswire BEIJING, Aug. 17, 2020 BEIJING, Aug. 17, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ:...
China Biologic Products to Report Second Quarter 2020 Financial Results PR Newswire BEIJING, Aug. 10, 2020 BEIJING, Aug. 10, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ:...
China Biologic Provides Additional Comments on the Xinjiang Deyuan and Shuanglin Transaction PR Newswire BEIJING, June 29, 2020 BEIJING, June 29, 2020 /PRNewswire/ -- China Biologic Products...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales